These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25835753)

  • 1. Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.
    Mortensen JK; Andersen G
    Expert Opin Drug Saf; 2015 Jun; 14(6):911-9. PubMed ID: 25835753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.
    Ramasubbu R
    J Clin Psychiatry; 2004 Dec; 65(12):1642-53. PubMed ID: 15641869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
    Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
    J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor: A Systematic Review and Meta-Analysis.
    Jones JS; Kimata R; Almeida OP; Hankey GJ
    Stroke; 2021 Aug; 52(9):2802-2808. PubMed ID: 34167325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.
    Chollet F; Rigal J; Marque P; Barbieux-Guillot M; Raposo N; Fabry V; Albucher JF; Pariente J; Loubinoux I
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):100. PubMed ID: 30353288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis.
    Zhou S; Liu S; Liu X; Zhuang W
    Medicine (Baltimore); 2020 Feb; 99(6):e19062. PubMed ID: 32028426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors for stroke recovery.
    Mead GE; Hsieh CF; Hackett M
    JAMA; 2013 Sep; 310(10):1066-7. PubMed ID: 24026602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-stroke depression: Mechanisms and pharmacological treatment.
    Villa RF; Ferrari F; Moretti A
    Pharmacol Ther; 2018 Apr; 184():131-144. PubMed ID: 29128343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Selective Serotonin Reuptake Inhibitors for Recovery after Stroke: A Meta-Analysis and Trial Sequential Analysis.
    Gu SC; Wang CD
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1178-1189. PubMed ID: 29276014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.
    Scheitz JF; Turc G; Kujala L; Polymeris AA; Heldner MR; Zonneveld TP; Erdur H; Curtze S; Traenka C; Brenière C; Wiest R; Rocco A; Sibolt G; Gensicke H; Endres M; Martinez-Majander N; Béjot Y; Nederkoorn PJ; Oppenheim C; Arnold M; Engelter ST; Strbian D; Nolte CH;
    Stroke; 2017 Dec; 48(12):3239-3244. PubMed ID: 29127269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence.
    Siepmann T; Penzlin AI; Kepplinger J; Illigens BM; Weidner K; Reichmann H; Barlinn K
    Brain Behav; 2015 Oct; 5(10):e00373. PubMed ID: 26516608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The psychopharmacology of brain vascular disease/poststroke depression.
    Jones M; Corcoran A; Jorge RE
    Handb Clin Neurol; 2019; 165():229-241. PubMed ID: 31727214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials.
    Su D; Zhang Y; Wang A; Shao D; Xu F; Dong M; Zhao L; Hu Y; Luo H
    Expert Rev Neurother; 2021 Oct; 21(10):1179-1189. PubMed ID: 34538154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
    Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
    J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance.
    Mortensen JK; Andersen G
    Expert Opin Pharmacother; 2021 Jun; 22(9):1157-1166. PubMed ID: 33530765
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs).
    Yi J; Lu J; Yang A; Marsh EB
    BMC Psychiatry; 2022 Nov; 22(1):722. PubMed ID: 36402974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV.
    Caballero J; Nahata MC
    Ann Pharmacother; 2005 Jan; 39(1):141-5. PubMed ID: 15562140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.